AFP and hepatocellular carcinoma: For this present study, we used data from the prospectively studied cohort of AN persons with CHB to compare the cost-effectiveness of HCC screening by 2 methods: screening by US semi-annually (US-alone method) versus semi-annual screening by AFP alone and switching to US alone if an AFP >10 ng/m was detected (AFP→US method).